Tested Applications
| Positive WB detected in | HeLa cells, HepG2 cells, PC-3 cells, rat testis tissue |
| Positive IP detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:12000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26208-1-AP targets CENPK in WB, IHC, IP, ELISA applications and shows reactivity with human, rat samples.
| Tested Reactivity | human, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23823 Product name: Recombinant human CENPK protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-269 aa of BC005400 Sequence: MNQEDLDPDSTTDVGDVTNTEEELIRECEEMWKDMEECQNKLSLIGTETLTDSNAQLSLLIMQVKCLTAELSQWQKKTPETIPLTEDVLITLGKEEFQKLRQDLEMVLSTKESKNEKLKEDLEREQRWLDEQQQIMESLNVLHSELKNKVETFSESRIFNELKTKMLNIKEYKEKLLSTLGEFLEDHFPLPDRSVKKKKKNIQESSVNLITLHEMLEILINRLFDVPHDPYVKISDSFWPPYVELLLRNGIALRHPEDPTRIRLEAFHQ Predict reactive species |
| Full Name | centromere protein K |
| Observed Molecular Weight | 32-35 kDa |
| GenBank Accession Number | BC005400 |
| Gene Symbol | CENPK |
| Gene ID (NCBI) | 64105 |
| RRID | AB_2880427 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BS16 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IP protocol for CENPK antibody 26208-1-AP | Download protocol |
| WB protocol for CENPK antibody 26208-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CENPK Polyclonal antibody (Cat# 26208-1-AP) has 6 citations. These appear in Cancer Cell Int, Bioengineered, Translational Oncology, Toxicology and Applied Pharmacology (×2), and OncoTargets and Therapy. The research fields span multiple cancer types, including lung adenocarcinoma, differentiated thyroid carcinoma, intrahepatic cholangiocarcinoma, clear cell renal cell carcinoma, breast carcinoma, and hepatocellular carcinoma, with applications primarily in Western blot and IHC for human samples.
| Species | Application | Title |
|---|---|---|
Cancer Cell Int Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
| ||
Bioengineered Overexpression of centromere protein K (CENPK) gene in Differentiated Thyroid Carcinoma promote cell Proliferation and Migration
| ||
Transl Oncol m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation | ||
Toxicol Appl Pharmacol The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway
| ||
Toxicol Appl Pharmacol Centromere protein K enhances the activation of YAP1/TAZ signal cascade to drive the progression of clear cell renal cell carcinoma
| ||
Onco Targets Ther Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1. |



